Africa is getting left behind! 72,5% of late-stage R&D projects by 20 top pharmaceutical companies analysed included no African country (source: 2024 Access to Medicine Index).

Addressing this gap is one of GLISTEN’s goals.

#2024accesstomedicineindex #clinicaltrials #globalsouth #clinicalresearch